Skip to content
  • Sunday, 26 July 2026
  • 2:51 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The Emergence of ChatLLM by Abacus AI: A Comprehensive Review of the All-in-One AI Workspace in 2026
Data Science & Bioinformatics

The Emergence of ChatLLM by Abacus AI: A Comprehensive Review of the All-in-One AI Workspace in 2026

Evan Lee Salim Jun 22, 2026 0

Artificial intelligence tools have transcended their niche origins to become indispensable components of daily professional workflows across virtually every sector.…

Read More
Data Science & Bioinformatics

Abacus AI’s ChatLLM Emerges as a Unified AI Solution Amidst Fragmented Tool Landscape

Evan Lee Salim Mar 24, 2026 0

In an increasingly complex landscape of artificial intelligence tools, Abacus AI has introduced ChatLLM, a platform designed to consolidate diverse…

Read More
TWiV 1292: Clinical update with Dr. Daniel GriffinFDA Commissioner Marty Makary Resigns Amidst Mounting Pressure and Regulatory TurmoilRevolutionary DNA Aptamers Offer New Hope in Identifying Elusive Senescent CellsBreakthrough in Quantum Entanglement Control Offers New Path for Ultra Precise Sensing and Fundamental Physics Research
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ